The live webcast may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.
About
Investors:
abraun@acumenpharm.com
Media:
AcumenPR@westwicke.com
Source:
2024 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.795 USD | +2.85% | +11.32% | -1.43% |
05-14 | Transcript : Acumen Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-08 | Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study | MT |
The live webcast may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.
About
Investors:
abraun@acumenpharm.com
Media:
AcumenPR@westwicke.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-1.43% | 222M | |
+29.13% | 49.18B | |
+0.96% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.29% | 26.09B | |
-22.70% | 18.71B | |
+8.15% | 13.26B | |
+32.02% | 12.32B | |
-0.71% | 11.99B |